Influence of novel GPR119 agonist in combination with metformin and sitagliptin on lipid profile and endothelial function in rats fed a high-fat diet-Reference-Cited by-同舟云学术

Influence of novel GPR119 agonist in combination with metformin and sitagliptin on lipid profile and endothelial function in rats fed a high-fat diet

Published:2018-06-30 Issue:2 Volume:17 Page:71-77
ISSN:1682-6655
Container-title:Regional blood circulation and microcirculation
language:
Short-container-title:Regional blood circulation and microcirculation

Author:

Kurkin D. V.¹,Bakulin D. A.¹,Volotova E. V.¹,Logvinova E. O.¹,Avdienko K. A.¹,Tyurenkov I. N.¹

Affiliation:

1. Federal State Budgetary Educational Institution of Higher Education «Volgograd State Medical University»

Publisher

FSBEI HE I.P. Pavlov SPbSMU MOH Russia

Subject

General Medicine

Reference18 articles.

1. Galstyan G. R., Karataeva E. A., Yudovich E. A. Evolyutsiya agonistov retseptorov glyukagonopodobnogo peptida-1 v terapii sakharnogo diabeta 2 tipa // Sakharnyi diabet. - 2017. - T. 20. - № 4. - S. 286-298. doi: 10.14341/dm8804. [Galstyan GR, Karataeva EA, Yudovich EA. Evolution of glucagon-like peptide-1 receptor agonists for type 2 diabetes treatment. Diabetes mellitus. 2017;20(4):286- 298. (In Russ)].

2. Degtyar' N. I., Gerasimenko N. D., Rasin M. S. Endotelii i sistemnoe vospalenie: rol' yadernykh transkriptsionnykh faktorov i terapevticheskie vozmozhnosti (obzor literatury) // Arterial'naya gipertenziya. - 2016. - № 4 (48). - S. 21-25. doi: 10.22141/2224-1485.4.48.2016.76991. [Degtjar NI, Gerasimenko ND, Rasin MS. Endothelium and systemic inflammation: role of nuclear transcription factors and therapeutic possibilities (literature review). Hypertension. 2016;(4):21-25. (In Russ)].

3. Dedov I. I., Kontsevaya A. V., Shestakova M. V. i dr. Ekonomicheskie zatraty na sakharnyi diabet 2 tipa i ego osnovnye serdechno-sosudistye oslozhneniya v Rossiiskoi Federatsii // Sakharnyi diabet. - 2016. - № 6. - S. 518-526. doi: 10.14341/DM8153. [Dedov II, Kontsevaya AV, Shestakova MV. Economic evaluation of type 2 diabetes mellitus burden and its main cardiovascular complications in the Russian Federation. Diabetes Mellitus. 2016;19(6):518-527. (In Russ)].

4. Dedov I. I., Shestakova M. V., Maiorov A. Yu. i dr. Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nym sakharnym diabetom / pod red. I. I. Dedova, M. V. Shestakovoi, A. Yu. Maiorova. - 8-i vyp. // Sakharnyi diabet. - 2017. - T. 20. - № 1S. - C. 1-121. doi: 10.14341/dm20171s8. [Dedov II, Shestakova MV, Mayorov AY, et al. Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV, Mayorov AY. 8th edition. Diabetes mellitus. 2017;20(1S):1-212. (In Russ)].

5. Mogil'nits'kaya L. A., Man'kovskii B. N. Povyshenie urovnya endotelial'nogo monotsitaktiviruyushchego peptida-II v syvorotke krovi bol'nykh arterial'noi gipertenziei v sochetanii s sakharnym diabetom 2-go tipa i ozhireniem // Ozhirenie i metabolizm. - 2016. - T. 13. - № 3. - S. 49-53. doi: 10.14341/omet2016349-53. [Mogylnytska LA, Mankovsky BN. An elevated serum level of endothelial monocyte activating polypeptide-II in patients with arterial hypertension with and without type 2 diabetes and obesity. Obesity and metabolism. 2016;13(3):49-53. (In Russ)].